1 Iso H, Moriyama Y, Sato S, et al. Serum total

homocysteine concentrations and risk of stroke and its

subtypes in Japanese[J]. Circulation, 2004, 109:2766-

2772.

2 Ribo M, Montaner J, Monasterio J, et al. Role

of homocysteine in the acute phase of stroke[J].

Neurologia, 2003, 19:10-14.

3 Delgado -Reye s CV, Wal l ig MA, Ga r row TA.

Immu noh i s t o chemic a l de t e c t ion of b e t a i ne -

homocysteine S-methyltransferase in human, pig, and

rat liver and kidney[J]. Arch Biochem Biophys, 2001,

393:184-186.

4 Mudd SH, Fi n kelst ei n JD, I r reve r re F, et al.

Transsulfuration in mammals. Microassays and tissue

distributions of three enzymes of the pathway[J]. J

Biol Chem, 1965, 240:4382-4392.

5 Jakubowski H. Molecular basis of homocysteine

toxicity in humans[J]. CMLS, 2004, 61:470-487.

6 Ueland PM. Homocysteine species as components of

plasma redox thiol status[J]. Clin Chem, 1995, 41:340-

342.

7 Chwatko G, Jakubowski H. The determination of

homocysteine–thiolactone in human plasma[J]. Anal

Biochem, 2005, 337:271-277.

8 Jakubowski H. Homocysteine is a protein amino acid

in humans. Implications for homocysteine-linked

disease[J]. J Biol Chem, 2002, 277:30425-30428.

9 Jakubowski H. Pathophysiological consequences

of homocysteine excess[J ]. J Nut r, 2006, 136:

1741S-1749S.

10 Molero AE, Altimari CC, Duran DA, et al. Total

pl a sma homo cys t e i ne va lue s among elde r ly

subjects:findings from the Maracaibo Aging Study[J].

Clin Biochem, 2006, 39:1007-1015.

11 Smi t h DEC, Smu ld e r s YM, Blom HJ, e t a l .

Determinants of the essential one-carbon metabolism

metabolites, homocysteine, S-adenosylmethionine,

S-adenosylhomocysteine and folate, in cerebrospinal

fluid[J]. Clin Chem Lab Med, 2012, 50:1641-1647.

12 Kelly PJ, Kistler JP, Shih VE, et al. Inflammation,

homocysteine, and vitamin B6 status after ischemic

stroke[J]. Stroke, 2004, 35:12-15.

13 Refsum H, Nurk E, Smith AD, et al. The Hordaland

Homocysteine Study:a community-based study of

homocysteine, its determinants, and associations with

disease[J]. J Nutr, 2006, 136:1731S-1740S.

14 王健, 金一. 慢性肾功能不全与Hcy水平的关系[J]. 中

国血液流变学杂志, 2007, 2:299-300.

15 Barbieri L, Verdoia M, Schaffer A, et al. Elevated homocysteine and the risk of contrast-induced

nephropathy:A cohort study[J/OL].http://ang.sagepub.

com/content/early/2014/05/14/0003319714533401.

16 Yajnik C, Deshpande SS, Lubree HG, et al. Vitamin

B12 deficiency and hyperhomocysteinemia in rural and

urban Indians[J]. JAPI, 2006, 54:775-782.

17 Jakubowski H. The molecular basis of homocysteine

thiolactone-mediated vascular disease[J]. Clin Chem

Lab Med, 2007, 45:1704-1716.

18 Richard E, Desviat LR, Ugarte M, et al. Oxidative

stress and apoptosis in homocystinuria patients with

genetic remethylation defects[J]. J Cell Biochem, 2013,

114:183-191.

19 Naruszewicz M, Mirkiewicz E, Olszewski AJ, et al.

Thiolation of low-density-lipoprotein by homocysteine

thiolactone causes increased aggregation and altered

interaction with cultured macrophages[J]. Nutr Metab

Cardiovasc Dis, 1994, 4:70-77.

20 Kerkeni M, Tnani M, Chuniaud L, et al. Comparative

study on in vitro effects of homocysteine thiolactone

and homocysteine on HUVEC cells:evidence

for a stronger proapoptotic and proinf lammative

homocysteine thiolactone[J]. Mol Cell Biochem, 2006,

291:119-126.

21 Jakubowski H. Protein homocysteinylation:possible

mechanism underlying pathological consequences

of elevated homocysteine levels[J]. FASEB J, 1999,

13:2277-2283.

22 Jakubowski H. Homocysteine thiolactone:metabolic

origin and protein homocysteinylation in humans[J]. J

Nutr, 2000, 130:377S-381S.

23 Bogdanski P, Pupek-Musialik D, Dytfeld J, et al.

Plasma homocysteine is a determinant of tissue

necrosis factor-α in hypertensive patients[J]. Biomed

Pharmacother, 2008, 62:360-365.

24 Undas A, Bro ek J, Jankowski M, et al. Plasma

homocysteine affects fibrin clot permeability and

resistance to lysis in human subjects[J]. Arterioscler

Thromb Vasc Biol, 2006, 26:1397-1404.

25 Sauls DL, Lockhart E, Warren ME, et al. Modification

of fibrinogen by homocysteine thiolactone increases

resistance to fibrinolysis:a potential mechanism of the

thrombotic tendency in hyperhomocysteinemia[J].

Biochemistry, 2006, 45:2480-2487.

26 Ferretti G, Bacchetti T, Moroni C, et al. Effect of

homocysteinylation of low density lipoproteins on

lipid peroxidation of human endothelial cells[J]. J Cell

Biochem, 2004, 92:351-360.

27 Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart

disease and stroke statistics-2010 update A report

from the American Heart Association[J]. Circulation, 2010, 121:e46-e215.

28 Sacco RL, Anand K, Lee HS, et al. Homocysteine and

the Risk of Ischemic Stroke in a Triethnic Cohort:The

Northern Manhattan Study[J]. Stroke, 2004, 35:2263-

2269.

29 Kelly PJ, Rosand J, Kistler JP, et al. Homocysteine,

MTHFR 677C→T polymorphism, and risk of ischemic

stroke:Results of a meta-analysis[J]. Neurology, 2002,

59:529-536.

30 Kim SJ, Choe YH, Bang OY. Are stroke biomarkers

seeing brain vessels in patients with ischemic stroke?

A C-reactive protein and homocysteine study[J].

Stroke, 2011, 42:1464-1468.

31 梁晨, 高社荣, 梁晓安, 等. 同型半胱氨酸、超敏C-反应

蛋白、纤维蛋白原与脑梗死严重程度及复发的相关性

分析[J]. 中华脑血管病杂志(电子版), 2013, 7:257-260.

32 Yang TH, Chang CY, Hu ML. Various forms of

homocysteine and oxidative status in the plasma

of ischemic-stroke patients as compared to healthy

controls[J]. Clin Biochem, 2004, 37:494-499.

33 Howard VJ, Sides EG, Newman GC, et al. Changes

in plasma homocyst (e) ine in the acute phase after

stroke[J]. Stroke, 2002, 33:473-478.

34 Omr a n i HQ, Sh a n d i z EE , Qa b a i M, e t a l .

Hyperhomocysteinemia, folateo and B12 vitamin in

Iranian patients with acute ischemic stroke[J]. ARYA

Atheroscler, 2011, 7:97-101.

35 张一娜, 王蕤, 武小薇. 血浆同型半胱氨酸水平与老年

脑梗死的关系[J]. 中国老年学杂志, 2007, 3:556-557.

36 刘飞凤. 同型半胱氨酸与动脉粥样硬化性脑血栓形成

患者发病严重程度及远期预后的相关性研究[D]. 上

海:复旦大学, 2012:28-41.

37 Feng C, Bai X, Xu Y, et al. Hyperhomocysteinemia

associates with small vessel disease more closely than

large vessel disease[J]. Int J Med Sci, 2013, 10:408-

412.

38 Khan U, Crossley C, Kalra L, et al. Homocysteine

and its relationship to stroke subtypes in a UK Black

population:The south London ethnicity and stroke

study[J]. Stroke, 2008, 39:2943-2949.

39 Pa r ne t t i L, Ca so V, Sa nt uc c i A, e t a l. Mi ld

hy perhomocysteinemia is a r isk-factor in all

etiological subtypes of stroke[J]. Neurol Sci, 2004,

25:13-17.

40 黄静, 苏平. 血浆同型半胱氨酸与缺血性脑卒中病因

分型及预后的关系研究[J]. 当代医学, 2011, 17:71-73.

41 An SA, Le e HB, Kim Y, e t a l. Pl a sma tot a l

homocysteine level is associated with the pulsatility

index of cerebral arteries in lacunar infarction[J].

Yonsei Med J, 2013, 54:819-824.

42 Held C, Sumner G, Sheridan P, et al. Correlations b e twe e n p l a sma h omo c y s t e i n e a n d f o l a t e

concentrations and carotid atherosclerosis in highrisk

individuals:baseline data from the Homocysteine

and Atherosclerosis Reduction Trial (HART)[J]. Vasc

Med, 2008, 13:245-253.

43 Wu XQ, Ding J, Ge AY, et al. Acute phase homocysteine

related to severity and outcome of atherothrombotic

stroke[J]. Euro J Intern Med, 2013, 24:362-367.

44 Saposnik G, Ray JG, Sheridan P, et al. Homocysteinelowering

therapy and stroke risk, severity, and

disability additional findings from the HOPE 2 trial[J].

Stroke, 2009, 40:1365-1372.

45 武云, 张文慧. 高同型半胱氨酸与脑梗死再发的相关

性研究[J]. 中国临床保健杂志, 2012, 15:262-263.

46 Hankey GJ1, Ford AH, Yi Q, et al. Effect of B

vitamins and lowering homocysteine on cognitive

impairment in patients with previous stroke or

transient ischemic attack:a prespecified secondary

analysis of a randomized, placebo-controlled trial and

meta-analysis[J]. Stroke, 2013, 44:2232-2239.

47 彭小莲. 高同型半胱氨酸血症与脑梗塞TOAST 亚型关

系及治疗研究[J]. 中国医药导刊, 2012, 14:2075-2075.

48 向建军, 许榕仙, 范岩峰, 等. 叶酸, VB6, VB12对血管

细胞粘附分子-1表达影响[J]. 中国公共卫生, 2009, 25:987-988.

49 Lee M, Hong KS, Chang SC, et al. Eff icacy of

homocysteine-lowering therapy with folic acid in

stroke prevention:A meta-analysis[J]. Stroke, 2010,

41:1205-1212.

50 Kelly PJ, Furie KL, Kistler JP, et al. Stroke in

young patients with hyperhomocysteinemia due to

cystathionine beta-synthase deficiency[J]. Neurology,

2003, 60:275-279.

51 洪小琴, 姜慧华. 叶酸和维生素B12、B6对脑卒中患者

血浆同型半胱氨酸、D-二聚体及血脂水平的影响[J].

中国医院药学杂志, 2014, 34:637-639.

52 Selhub J, Jacques PF, Rosenberg IH, et al. Serum

total homocysteine concentrations in the third

Na t iona l He a lt h a nd Nut r it ion Exami na t ion

Survey (1991–1994):population reference ranges

and contribution of vitamin status to high serum

concentrations[J]. Ann Intern Med, 1999, 131:331-339.

53 Toole JF, Malinow MR, Chambless LE, et al.

Lowering homocysteine in patients with ischemic

stroke to prevent recur rent stroke, myocardial

infarction, and death:the Vitamin Intervention for

Stroke Prevention (VISP) randomized controlled

trial[J]. JAMA, 2004, 291:565-575.